Inhibition of leukocyte adherence and transendothelial migration in cultured human liver vascular endothelial cells by prostaglandin E1

Hepatology

Volumn 27, Issue 3, 1998, Pages 822-828

  Lou, Jinning ^a   Bühler, Leo ^a   Deng, Shaoping ^a   Mentha, Gilles ^a   Montesano, Roberto ^a   Grau, Georges E ^a   Morel, Philippe ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD18 ANTIGEN; CELL ADHESION MOLECULE; CYTOKINE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; OXYGEN RADICAL; PROSTAGLANDIN E1; TUMOR NECROSIS FACTOR;

ANTIGEN EXPRESSION; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; GRAFT FAILURE; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; LIVER ISCHEMIA; LIVER PROTECTION; LIVER TRANSPLANTATION; OXIDATIVE STRESS; PRIORITY JOURNAL; REPERFUSION INJURY;

ALPROSTADIL; ANTIGENS, CD18; CELL ADHESION; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; LEUKOCYTES; LIVER; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0031915260     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270326     Document Type: Article

References (50)

1. Clavien PA, Harvey PR, Strasberg SM. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation 1992;53:957-978
2. Xu HS, Rosenlof LK, Pruett TL, Jones RS. Prostaglandin E1 increases survival with extended anhepatic phase during liver transplantation. Ann Surg 1994;220:53-58.
3. Hanazaki K, Kuroda T, Kajikawa S, Shiohara E, Haba Y, Iida F. Prostaglandin E protects liver from ischemic damage. J Surg Res 1994;57:380-384.
4. Mollison LC, Angus PW, Jones RM. Prostaglandin E1 for the treatment of primary non-function of the donor organ in liver transplantation. Med J Aust 1991;155:51-53.
5. Grazi GL, Mazziotti A, Sama C, Stefanini GF, Gozzetti G. Reversal of primary liver graft non-function using prostaglandins. Hepatogastroenterology 1991;38:254-256.
6. Atalla SL, Toledo-Pereyra LH, Mackenzie GH, Cederna JP. Influence of oxygen-derived free radical scavengers on ischemic liver. Transplantation 1985;40:585-590.
7. Marubayashi S, Dohi Y, Kawasaki T. Role of free radicals in ischemic rat liver cell injury: prevention of damage by a-tocopherol administration. Surgery 1986;99:184-192.
8. Toledo-Pereyra LH, Simmons RL, Najarian JS. Protection of the ischemic liver by donor pretreatment before transplantation. Am J Surg 1975;129: 513-517.
9. Colletti LM, Remick DG, Burtch GD, Kvmkel SL, Stieter RM, Campbell Jr DA. Role of tumor necrosis factor-a in the patho-physiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 1990;85:1936-1943.
10. Jaeschke H, Farhood A, Smith CW. Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J 1990;4:3355-3359.
11. Grisham MB, Hernandez LA, Granger DN. Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol 1986;251: G567-G574.
12. Dreyer WJ, Michael LH, West MS, Smith CW, Rothlein R, Rossen RD, Anderson DC, et al. Neutrophils accumulation in ischemic canine myocardium. Insights into time course, distribution, and mechanism of localization during early reperfusion. Circulation 1991;84:400-411.
13. Ma X, Lefer DJ, Lefer AM, Rothlein R. Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation 1992;86: 937-946.
14. Porter KA. Pathology of liver transplantation. Transplant Rev 1969;2:129-170.
15. Post S, Menger MD, Rentsch M, Gonzalez AP, Herfarth C, Messmer K. The impact of arterialization on hepatic microcirculation and leukocyte accumulation after liver transplantation in the rat. Transplantation 1992;54:789-794.
16. Granger DN, Benoit JN, Suzuki M, Grisham MB. Leukocyte adherence to venular endothelium during ischemia-reperfusion. Am J Physiol 1989; 257:G683-G688.
17. Granger DN, Kvietys PR, Perry MA. Leukocyte-endothelial cell adhesion induced by ischemia and reperfusion. Can J Physiol Pharmacol 1993;71:67-75.
18. Vollmar B, Menger MD, Glasz J, Leiderer R, Messmer K. Impact of leukocyte endothelial cell interaction in hepatic ischemia-reperfusion injury. Am J Physiol 1994;30:G786-G793.
19. Mori E, del Zoppo GJ, Chambers D, Copeland BR, Arfors KE. Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboon. Stroke 1992;23:712-718.
20. Fisher M, Arpano MM. Inhibition of stimulated human leukocyte hydrogen peroxide generation by a novel antioxidant, OPC-14117. J Neurol Sci 1992;109:107-110.
21. Ricevuti G, Mazzone A, Pasotti D, de Sevi S, Specchia G. Role of granulocytes in endothelial injury in coronary heart disease in humans. Atherosclerosis 1991;91:1-14.
22. Godin C, Caprani A, Dufaux J, Flaud P. Interactions between neutrophils and endothelial cells. J Cell Sci 1993;106:441-452.
23. Schreiner GF, Kamei T, Lefkowith J, Flye MW. Modulation of kinetics of the initial leukocyte migration into renal allografts by 16,16-dimethyl PGE2. Transplantation 1993;56:417-422.
24. Oppenheimermarks N, Kavanaugh AF, Lipsky PE. Inhibition of the transendothelial migration of human T lymphocytes by prostaglandin E (2). J Immunol 1994;152:5703-5713.
25. Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol 1976;13:29-83.
26. Salavert A, Iynedjian PB. Regulation of phosphoenolpyruvate carboxykinase (GTP) synthesis in rat liver cells. J Biol Chem 1982;257:13404-13412.
27. Delaossa JC, Malago M, Gewertz BL. Neutrophil-endothelial cell binding in neutrophil-mediated tissue injury. J Surg Res 1992;53:103-107.
28. Jaeschke H, Farhood A, Bautista AP, Spolarics Z, Spitzer JJ, Smith CW. Functional inactivation of neutrophils with a MAC-1 (CD11b/CD18) monoclonal antibody protects against ischemia-reperfusion injury in rat liver. HEPATOLOGY 1993;17:915-923.
29. Horgan MJ, Wright SD, Malik AB. Antibody against leukocyte integrin (CD18) prevents reperfusion-induced lung vascular injury. Am J Physiol 1990;259:L315-L319.
30. Kling D, Fingerle J, Harlan JM. Inhibition of leukocyte extravasation with a monoclonal antibody to CD18 during formation of experimental intimal thickening in rabbit carotid arteries. Arterioscler Thromb 1992;12:997-1007.
31. Sottile A, Venza M, Venza I, Teti D. Prostaglandins affect the respiratory burst of human neutrophils. Immunopharmacol Immunotoxicol 1995; 17:311-321.
32. Harada S, Nagy JA, Sullivan KA, Endo N, Rodan GA, Rodan SB. Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. J Clin Invest 1994;93:2490-2496.
33. Yong T, Mayhan WG. Effect of prostaglandin E1 on leukotriene C4-induced increases in vascular permeability of hamster cheek pouch. Inflammation 1992;16:159-167.
34. Gold KN,Weyand CM, Goronzy JJ. Modulation of helper T cell function by prostaglandins. Arthritis Rheum 1994;37:925-933.
35. Colletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell DA. Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia reperfusion injury in the rat. J Clin Invest 1990;85:1936-1943.
36. Seekamp A,Warren JS, Remick DG, Till GO,Ward PA. Requirements for tumor necrosis factor-alpha and interleukin-1 in limb ischemia reperfusion injury and associated lung injury. Am J Pathol 1993;143:453-463.
37. Carles J, Fawaz R, Hamoudi NE, Neaud V, Balabaud C, Bioulacsage P. Preservation of human liver grafts in UW solution - ultrastructural evidence for endothelial and Kupffer cell activation during cold ischemia and after ischemia-reperfusion. Liver 1994;14:50-56.
38. Arnould T, Michiels C, Remacle J. Increased PMN adherence on endothelial cells after hypoxia-involvement of PAF, CD18/CD11b, and ICAM-1. Am J Physiol 1993;264:C1102-C1110.
39. Snijdewint FGM, Kalinski P, Wierenga EA, Bos JD, Kapsenberg ML. Prostaglandin-E(2) differentially modulates cytokine secretion profiles of human T-helper lymphocytes. J Immunol 1993;150:5321-5329.
40. Dibattista JA, Martel-Pelletier J, Fujimoto N, Obata K, Zafarullah M, Pelletier JP. Prostaglandin E2 and E1 inhibit cytokine-induced metalloprotease expression in human synovial fibroblasts. Mediation by cyclic-AMP signalling pathway. Lab Invest 1994;71:270-278.
41. Pober JS, Slowik MR, Deluca LG, Ritchie AJ. Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1. J Immunol 1993;150:5114-5123.
42. Kim JS, Chopp M, Chen H, Levine SR, Carey JL, Welch KMA. Adhesive glycoproteins CD11a and CD18 are upregulated in the leukocytes from patients with ischemic stroke and transient ischemic attacks. J Neurol Sci 1995;128:45-50.
43. Kavanaugh AF, Lightfoot E, Lipsky PE, Oppenheimermarks N. Role of CD11/CD18 in adhesion and transendothelial migration of T-cells - analysis utilizing CD18-deficient T-cell clones. J Immunol 1991;146:4149-4156.
44. Dustin ML, Springer TA. T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 1989;341:619-622.
45. Grau GE, Lou J. TNF in vascular pathology: importance of plateletendothelium interactions. Res Immunol 1993;144:355-363.
46. Belloni PN, Carney DH, Nicolson GL. Organ-derived microvessel endothelial cells exhibit differential responsiveness to thrombin and other growth factors. Microvasc Res 1992;43:20-45.
47. Charo I, Karasek S, Davision MA, Golddstein PM. Prostaglandin I2 is not a major metabolite of arachidonic acid in cultured endothelial cells from human foreskin microvessels. J Clin Invest 1984;74:914-919.
48. Gerritsen ME, Printz MP. Site of prostaglandin synthesis in bovine heart and isolated bovine coronary microvessels. Circ Res 1981;5:1152-1163.
49. Lou JN, Dayer J-M, Grau GE, Burger D. Direct cell-cell contact with stimulated T lymphocytes induces the expression of cell adhesion molecules and cytokines by human brain microvascular endothelial cells. Eur J Immunol 1996;26:1307-1313.
50. Pober JS, Cotran RS. Cytokines and endothelial cell biology. Physiol Rev 1990;70:427-451.